Your browser doesn't support javascript.
loading
Allele frequency spectrum of known ankylosing spondylitis associated variants in a Swedish population.
Mathioudaki, A; Nordin, J; Kastbom, A; Söderkvist, P; Eriksson, P; Cedergren, J; Lindblad-Toh, K; Meadows, Jrs.
Afiliación
  • Mathioudaki A; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Nordin J; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Kastbom A; Department of Rheumatology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Söderkvist P; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Eriksson P; Department of Rheumatology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Cedergren J; Department of Rheumatology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Lindblad-Toh K; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Meadows J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Scand J Rheumatol ; 51(1): 21-24, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34169791
ABSTRACT

Objective:

The genetic predisposition to ankylosing spondylitis (AS) has been most widely studied in cohorts with European ancestry. However, within Europe, disease prevalence is higher in Sweden. Given this, we aimed to characterize known AS susceptibility variants in a homogeneous Swedish data set, assessing reproducibility and direction of effect.

Method:

The power to detect association within an existing Swedish targeted sequencing study (381 controls; 310 AS cases) was examined, and a set of published associations (n = 151) was intersected with available genotypes. Association to disease was calculated using logistic regression accounting for population structure, and HLA-B27 status was determined with direct polymerase chain reaction genotyping.

Results:

The cases were found to be 92.3% HLA-B27 positive, with the data set showing ≥ 80% predictive power to replicate associations, with odds ratios ≥ 1.6 over a range of allele frequencies (0.1-0.7). Thirty-four markers, representing 23 gene loci, were available for investigation. The replicated variants tagged MICA and IL23R loci (p < 1.47 × 10-3), with variable direction of effect noted for gene loci IL1R1 and MST1.

Conclusion:

The Swedish data set successfully replicated both major histocompatibility complex (MHC) and non-MHC loci, and revealed a different replication pattern compared to discovery data sets. This was possibly due to population demographics, including HLA-B27 frequency and measured comorbidities.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espondilitis Anquilosante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Scand J Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espondilitis Anquilosante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Scand J Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Suecia